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Summary
Myxoid heart disease is frequently encountered in the
general population. It corresponds to an etiologically
heterogeneous group of diseases, idiopathic mitral valve
prolapse (IMVP) being the most common form. A rarely
observed form of myxoid heart disease, X-linked myx-
omatous valvular dystrophy (XMVD), is inherited in an
X-linked fashion and is characterized by multivalvular
myxomatous degeneration; however, the histopatholog-
ical features of the mitral valve do not differ significantly
from the severe form of IMVP. In this article, we describe
the genetic analysis of a large family in which XMVD
is associated with a mild hemophilia A. The coagulation
factor VIII gene position in Xq28 provided a starting
point for the genetic study, which was conducted by use
of polymorphic markers. Two-point linkage analysis
confirmed this localization, and a maximum LOD score
of 6.57 was found at for two polymorphic mi-v  0
crosatellite markers, INT-3 and DXS1008, the first one
being intronic to the factor VIII gene. Haplotype analysis
of this chromosomal region allowed the definition of an
8-cM minimal interval containing the gene for XMVD,
between DXS8011 and Xqter.
Introduction
Two inherited and nonsyndromic myxoid valvular heart
dystrophies have been reported, and, of them, idiopathic
mitral valve prolapse (IMVP), in its familial form or in
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sporadic cases, is by far the most commonly encoun-
tered: IMVP is observed with a 4% and 2% frequency
in the young adult population (for women and men,
respectively) (Savage et al. 1983). Most affected patients
are asymptomatic, but some of them suffer from atypical
chest pain. Endocarditis, spontaneous cordal rupture,
progressive mitral regurgitation, and sudden death are
rare complications. Histologically, in the severe adult
form, the mitral valve shows a myxomatous degenera-
tion (King et al. 1982; Tamura et al. 1995); the mode
of inheritance of this trait is usually considered to be
autosomal dominant, with an age- and sex-dependent
expression (Hunt and Sloman 1969; Kramer et al. 1981;
Devereux et al. 1982). IMVP is the most common fa-
milial cardiovascular abnormality in humans to be in-
herited in a Mendelian fashion. By use of linkage analysis
in some informative families, four collagen genes have
been excluded as candidate genes for IMVP (Henney et
al. 1989; Wordsworth et al. 1989); however, this result
cannot be taken as definitive, since genetic heterogeneity
is possible, which could, in addition, underlie the severity
of the lesions.
The second myxoid valvular heart disease is called X-
linked myxomatous valvular dystrophy (XMVD), or
sex-linked valvular dysplasia (MIM 314400; McKusick
1997). This congenital cardiac dystrophy is thought to
be rare and was first identified three decades ago (Mon-
teleone and Fagan 1969). The mode of inheritance has
been defined as X-linked and recessive. Clinically, the
male patients present with multivalvular defects that, in
a number of cases, necessitate surgery. Histologically, the
cardiac valves show a myxomatous degeneration with
secondary calcification, and the histological features of
pathological mitral valves are reminiscent of severe
forms of IMVP. Only males have been reported as being
affected, whereas obligate carrier females have been reg-
istered as unaffected (Monteleone and Fagan 1969;
Newbury-Ecob et al. 1993).
So far, and possibly because of the small size of the
pedigrees reported, none of the inherited forms of non-
syndromic cardiac valvular dystrophy has been mapped
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on human chromosomes, and thus no responsible gene
has been identified. We present here the first large
XMVD family that allowed a precise genetic study of
this disease. The genetic linkage analysis, facilitated by
the X-linked mode of inheritance and by the association
with a mild form of hemophilia A in this pedigree, per-
mitted a rapid chromosomal mapping of the XMVD
gene.
Subjects, Material, and Methods
Family Studies, Phenotyping of Patients, and
Collection of Materials
This large five-generation XMVD pedigree is of
French origin and was not consanguineous (fig. 1). The
cardiac clinical status of 92 members has been ascer-
tained through two-dimensional standard echocardi-
ography and color-coded Doppler analysis according to
the recommendations of the American Society of Ech-
ocardiography and the criterion defined for the mitral
apparatus (Henry et al. 1980; Weissman et al. 1994).
The coagulation status was analyzed following standard
protocols. The linkage analysis did not include deceased
family members, for whom clinical status could be in-
ferred only anecdotally from living relatives. All patients
who participated in this study granted informed consent
with respect to the genetic analysis.
Clinical Characterization of XMVD
Detailed clinical features of this obviously X-linked
disease (no male-to-male transmission was recorded in
this family), including the previously undescribed oc-
currence of moderately affected women, are to be re-
ported in detail elsewhere (Trochu JN, Schott JJ, Kyndt
F, Gueffet JP, Be´nichou B, Le Marec H., unpublished
data). Patients were considered to be affected when ech-
ocardiographic analysis identified at least a trivial re-
gurgitation of one of the left cardiac valves and/or when
an obvious dystrophy of the mitral valve was present,
whether or not associated with billowing. They were
considered to be unaffected when the echocardiogram
was normal or when the regurgitation was physiological
(Henry et al. 1980; Weissman et al. 1994).
Nine male patients were obviously affected by mitral
valve dystrophy, and six of them had severe or moderate
aortic regurgitation. These findings led to cardiac valve
surgery in four cases: patients III-4, III-10, and III-14
underwent surgery for severe aortic regurgitation and
had moderate mitral regurgitation as well, and patient
V-11 had mitral valvuloplasty because of severe mitral
regurgitation secondary to mitral valve prolapse. His-
tological examination of the excised aortic valves
showed typical features of myxomatous valvular dys-
trophy. The five other affected males had obvious mitral
valvular dystrophy, as ascertained by echocardiographic
examination. In all affected males, mitral valves were
characterized by thicker anterior (AML) and posterior
(PML) leaflets ( mm vs. mm, for4.7 0.7 2.0 0.4
AML, and mm vs. mm, for PML;3.8 0.6 1.8 0.4
), longer AML and PML ( mm vs.P ! .0001 28.1 2.4
mm and mm vs. mm,22.1 4.4 13.6 1.7 10.1 1.8
respectively; ), and larger mitral annular di-P ! .001
ameter at end diastole ( mm vs.31.3 3.0 23.8 5.1
mm; ). Since, in this pedigree, males appearedP ! .001
either clearly affected or not affected at all, we were
prompted to consider that the penetrance was full. Fur-
thermore, a mild form of hemophilia A was systemati-
cally associated with this valvular disease, whereas
XMVD-unaffected males were not hemophiliacs. This
defect was investigated biologically and did not show
any difference with classical hemophilia A, suggesting
that hemophilia A and XMVD cosegregate by coinci-
dence in this particular family (see Discussion).
As for females, the valvular defect was less severe;
none of them had significant echocardiographic feature
of valvular dystrophy (i.e., echocardiographic thickening
and lengthening of the mitral valve leaflets and enlarge-
ment of the mitral annulus), but 12 of them presented
with mild to moderate aortic and/or mitral regurgitation.
Finally, a karyotype analysis for patient V-11 did not
detect any chromosomal abnormality.
DNA Microsatellite Marker Analysis
DNA was extracted from whole blood by means of
standard protocols. Since the F8 gene lies in Xq28 and
XMVD cosegregates with hemophilia A, a series of mi-
crosatellite markers spanning the entire Xq28 region was
analyzed.
Four of the microsatellites used here—DXS998,
DXS8091, DXS8011, and DXS8061—have been char-
acterized at Ge´ne´thon (http://www.genethon.fr/) (Dib et
al. 1996); another one, INT-13, is a dinucleotide marker
located within F8 gene intron 13 (Lalloz et al. 1994);
the last one, DXS1108, lies close to the Xq pseudoau-
tosomal region (Freije et al. 1992). PCR reactions were
carried out in 20-ml volumes, containing 2 ml diluted
genomic DNA (∼200 ng), 1# Taq buffer (50 mM KCl,
1.5 mM MgCl2, 10 mM Tris-HCl pH 9), 0.2 mM each
dNTP, 1 mM each of both oligonucleotide primers, and
1 unit Taq polymerase (Pharmacia); the mix was then
subjected to 30 cycles of PCR amplification, under an-
nealing conditions adapted for each primer, with a Peltier
thermal cycler 200 (MJ Research). Two microliters of
each PCR product were then diluted with 1 ml of loading
buffer, denatured for 2 min at 94C, and kept on ice
until separation on a 6% denaturing polyacrylamide gel;
the DNA was then transferred onto a nitrocellulose
membrane (Hybond, Amersham), hybridized to a la-
Figure 1 XMVD pedigree. Hatched symbols denote affected patients; symbols for affected males are darker than those for females, to indicate that males are simultaneously affected by severe
XMVD and by hemophilia A. Marker order is as follows (top to bottom): DXS998, DXS8091, DXS8011, DXS8061, INT-13, and DXS1108. The ancestral disease-bearing haplotype is boxed.
Blackened arrows indicate recombinations of parental alleles. Haplotypes in brackets have been reconstructed.
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Table 1
Pairwise LOD Scores for the XMVD Locus, Male-Only Study
MARKER
LOD SCORE AT v 
0 .01 .05 .1 .2 .3 .4
DXS998 4.37 .17 1.00 1.42 1.50 1.17 .62
DXS8091 4.38 2.95 3.36 3.27 2.71 1.94 1.00
DXS8011 1.27 .02 .54 .68 .66 .52 .30
DXS8061 3.84 3.78 3.54 3.22 2.53 1.76 .89
INT-13 5.91 5.81 5.41 4.89 3.81 2.64 1.34
DXS1108 5.91 5.81 5.41 4.90 3.82 2.65 1.35
Figure 2 Chromosome Xq28 backbone. Polymorphic markers
used for linkage analysis are represented. The XMVD gene has been
mapped between DXS8011 and Xqter. Factor VIII gene, which is mu-
tated in hemophilia A, has is also represented.
beled 18-mer CA repeat oligonucleotide probe, revealed
as recommended by the company (ECL direct nucleic
acid labeling and detection system, Amersham), and vi-
sualized by autoradiography.
Linkage Analysis
The order and intermarker distances given here were
as published elsewhere (Dib et al. 1996), and the linkage
analyses were carried out on a personal computer using
the MLINK features of the LINKAGE program 5.2 (La-
throp and Lalouel 1984). The XMVD disease-allele fre-
quency was assumed to be .00001, on the basis of the
rarity of reported cases. Values of .02 and .04 were used
to account for possible phenocopies for males and fe-
males, respectively, which correspond to IMVP fre-
quency in the general population (Savage et al. 1983).
Allele frequencies were arbitrarily assigned a value of
, where n refers to the number of alleles observed.1/n
Since incorrect parameters for linkage analysis may give
false results, positive LOD scores were tested for ro-
bustness by use of either published frequencies or the
frequencies observed in this family. The results were al-
most identical in every case, suggesting that the number




Patient DNAs were typed with six CA repeat poly-
morphic markers, one of them being intronic to the F8
gene, spanning a total of 19 cM, and haplotypes were
reconstructed for important absent or deceased family
members (fig. 1). Since the occurrence of this disease has
been reported only twice, and for very small pedigrees,
the definition of the parameters for LOD score calcu-
lations was not obvious. Only male phenotypes were
first used to calculate the LOD scores, thus avoiding the
use of an arbitrary penetrance value for females.
The results of the two-point linkage analysis are given
in table 1. An identical maximum LOD score of 5.91 at
was obtained for INT-13 and DXS1108. Haplo-v  0
type analyses permitted the reconstruction of the ances-
tral disease-bearing haplotype, which was harbored by
the ancestor male I-1, who transmitted the mutant allele
for XMVD and hemophilia A to all of his daughters.
Furthermore, four recombination events have been char-
acterized in male patients III-3, IV-52, V-11, and V-13,
allowing precise delineation of the XMVD candidate
region to a 8-cM interval between markers DXS8011
and Xqter (fig. 2).
Retrospectively, it has been possible to calculate the
penetrance value of valvular regurgitation for females,
which may affect XMVD heterozygous patients. Among
17 females harboring the complete minimal disease-
linked haplotype, only 10 had a mitral and/or aortic
valve abnormality, thus giving a penetrance value of .59.
The subsequent two-point linkage analysis gave an iden-
tical and increased maximum LOD score of 6.57 at
for INT-13 and DXS1108, which is consistentv  0
with the male-only linkage analysis (table 2). Two of the
clinically affected women (III-16 and IV-3) did not in-
herit the disease haplotype and thus appear to be phe-
nocopies.
Genomic Analysis around the F8 Gene
Because XMVD and hemophilia A cosegregate in this
family, despite the fact that both diseases exist as isolated
entities, it was of interest to check whether a single mu-
tation event—namely, a large genomic deletion encom-
passing either the 5′ or 3′ sequences—could have simul-
taneously damaged F8 gene and other genes, thus
explaining this complex phenotype. Two sets of oligo-
nucleotides immediately adjacent to the 5′ or 3′ F8 gene
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Table 2
Pairwise LOD Scores for the XMVD Locus, Male and Female Study
LOD SCORE AT v 
MARKER 0 .01 .05 .1 .2 .3 .4
DXS998 10.32 .72 .49 .97 1.19 1.00 .57
DXS8091 10.66 2.81 3.27 3.25 2.89 2.10 1.14
DXS8011 4.71 .64 1.18 1.27 1.12 .83 .45
DXS8061 3.91 3.87 3.69 3.43 2.77 1.99 1.05
INT-13 6.57 6.46 6.03 5.48 4.36 3.11 1.65
DXS1108 6.57 6.47 6.07 5.56 4.48 3.22 1.71
sequences were designed and used in PCR experiments,
in order to detect possible deletions in XMVD-affected
males. No deletion was observed (data not shown).
Discussion
The similar symptomatology in this family and in the
two other reported pedigrees and the same mode of in-
heritance permits us to classify them as most likely af-
fected by the same disease, namely XMVD.The clinical
association of hemophilia A and XMVD raised the pos-
sibility that a single mutation event could have led to
the observed complex phenotype. Indeed, prior to the
linkage analysis, it could not be excluded that the mu-
tation on a single gene located anywhere on the X chro-
mosome, and simultaneously involved in factor VIII bi-
ological activity regulation and cardiac valve integrity,
would be the molecular basis of this uncommon clinical
association. In order to verify that the coagulation ab-
normality was indeed linked to the F8 gene, haplotype
analyses were conducted throughout the Xq28 telomeric
region. As expected, the segregation of hemophilia A
was absolutely compatible with the existence of an F8
gene mutation.
Two-point linkage analyses between each marker and
the male XMVD phenotype were performed in parallel.
This allowed the mapping of the cardiac defect to an
Xq28 8-cM region encompassing the F8 gene, with a
very significant maximum LOD score value. A subse-
quent linkage analysis including all male and female pa-
tients was performed, and the results supported the
Xq28 localization, providing evidence that the hetero-
zygous status for XMVD may be echographically de-
tectable in females. Two phenocopies were identified,
which is in agreement with the 4% estimated occurrence
of IMVP in the general female population. Cases of mod-
erately affected females had not been reported previously
for XMVD, and the occurrence of such cases in this
pedigree may be due to skewed X inactivation, as has
been shown for dyskeratosis congenita, or to the pres-
ence of an allelic variant (Devriendt et al. 1997). From
the haplotype analysis, a penetrance value of .59 was
estimated for females. The four females (III-32, IV-40,
V-1, and V-12) who harbored recombinations within the
candidate region were not echographically affected and
thus did not allow refinement of the candidate region.
Direct sequence analysis of the large F8 gene is in
progress, in order to identify the causative F8 gene mu-
tation. Nevertheless, many arguments clearly played in
favor of the occurrence of two independent mutation
events: (i) both hemophilia A and XMVD exist as sep-
arate clinical entities; (ii) although hemophilia A is a
frequent disease, this particular association had never
before been reported; (iii) a contiguous gene syndrome
is very unlikely, because large F8 gene deletions are as-
sociated with severe forms of hemophilia A and also
because no large deletion has been detected in this family
by PCR on F8 gene neighboring sequences; and (iv) sev-
eral cases of severe hemophilia A with large deletions of
the F8 gene, either encompassing the whole gene or telo-
meric or centromeric parts of it and extending to neigh-
boring regions, have been reported, whereas no valvu-
lopathy was associated, which also excludes the
possibility that the gene intronic to the F8 gene may be
involved in XMVD (Kenwrick et al. 1992; Murru et al.
1994).
Xq28 is known to contain numerous genes involved
in X-linked diseases, including two pathologies involving
the heart: fatal X-linked infantile cardiomyopathy and
Barth syndrome, a disease for which the mutant gene
has been recently identified (Gedeon et al. 1995; Bione
et al. 1996). Although these diseases are not typically
associated with valvular dystrophy, at the present time,
we cannot formally exclude that XMVD is allelic to one
of these syndromes; XMVD may more likely be the re-
sult of a mutation in a gene involved in extracellular
matrix integrity, since syndromic mitral valvular dystro-
phy is frequent in heritable disorders of connective tis-
sue, such as Marfan and Ehlers-Danlos syndromes and
osteogenesis imperfecta (Beighton 1969; Pyeritz and
Wappel 1983). Interestingly, a gene located within the
Xq28 minimal region, BGN, codes for a protein called
“biglycan,” which is an interesting candidate gene be-
cause it is found as a constituent of extracellular matrices
in many tissues (Fisher et al. 1989; Traupe et al. 1992).
However, complete exon sequence analysis in two fam-
ilies of XMVD did not detect any mutation in this gene
(authors’ unpublished data). Analysis of other candidate
genes is in progress in our laboratory.
This first mapping of the gene for a nonsyndromic
valvular dystrophy should help clarify the nosology of
this heterogeneous group of diseases. Furthermore, this
work paves the way for the identification of the molec-
ular basis of this disease, which may ultimately shed light
on the physiopathology of the very frequent IMVP.
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